Online Learning
Member Login
  • Home
  • About us
    • Leadership
    • Our Founding 100
  • Join us
    • Contribute to our PAC
    • Our Federal PAC
    • State Affiliate Caucus
    • State Affiliate Caucus Application
  • News
    • Resources
    • COVID-19 Resources
  • Support NDASA
  • Awards
  • Courses
  • Get involved
    • Committees
    • Board elections
  • Job Board
  • Member Login
  • NDASA University
    • My Account
    • My Courses
    • NDASA University Partner Program
  • NDASA Accreditation
  • Policies
  • Shop
  • Training opportunities
    • Webinars
      • Webinar Library
  • Security Policy
  • Refund Policy
  • Privacy Policy
  • Shipping Policy
  • Become a Trainer
  • Preferred Provider Program
  • TPA Accredidation Application
  • Mentorship
  • Meet Our Sponsors
  • Mentorship Program Pricing
  • Join our affiliate program
  • Webinar Library
  • Mentor Program Training
  • 2022 Annual Conference Exhibitors
  • 2022 National Conference & Trade Show
  • 2022 National Conference & Trade Show
  • Pre-Conference Training Special
  • Conference 2022: Featured Speakers
NDASA logo
  • About
    • Leadership
  • Training
    • NDASA University
      • My Courses
    • Webinars
    • Accreditation
    • Mentorship
    • Webinar Library
    • 2021 Conference On Demand
  • Get involved
    • Committees
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
    • COVID-19 Resources
  • Events
    • 2023 Conference Pre-Registration
    • 2022 National Conference & Trade Show
    • 2021 Conference Highlights
    • Conference On Demand
    • IFDAT Conference
    • East Coast Job-Jam
  • Support
    • Sponsorships & Advertising
  • Contact

U.S. DOT Recreational Marijuana Notice

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources

“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program.  The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...

U.S. DOT Medical Marijuana Notice

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources

“Medical Review Officers will not verify a drug test as negative based upon information that a physician recommended that the employee use “medical marijuana.” Please note that marijuana remains a drug listed in Schedule I of the Controlled Substances Act. It remains...

Video: ‘Don’t drop marijuana’

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources, Uncategorized

“Don’t Drop Marijuana” explains why marijuana and THC, the active ingredient of the cannabis plant, should not be dropped from drug-testing programs and panels. Please click here to review the video on Vimeo.com.  This video is produced by Drug Free Business, a...

Meet the National Marijuana Initiative

by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, For Employers and Workplace Safety & Wellness Professionals, Marijuana & CBD, Resources

The National Marijuana Initiative (NMI) is one of three national initiatives within the federal High Intensity Drug Trafficking Areas (HIDTA) Program. The White House Office of National Drug Control Policy has established HIDTA task forces all over the country to...

NDASA answers to frequently asked questions about marijuana and the workplace

by NDASA | Apr 23, 2021 | For Employers and Workplace Safety & Wellness Professionals, Resources

As NDASA Members, we are often asked these common questions that can cause confusion and frustration for employers when it comes to employee marijuana use, the workplace drug & alcohol policy and workplace safety. Below is a simple Q&A you may find helpful...
« Older Entries

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • May 18, 2022A Sad Loss for Our Industry
  • Apr 26, 2022NDASA’s Response to Proposed Guidelines for Oral Fluid Testing and Other Changes to 49 CFR Part 40
  • Apr 25, 2022Start Your Engines for Conference 2022
  • Mar 15, 2022Fast, Clean, Accurate Alcohol Testing – The Future is Here
  • Mar 03, 2022Commit to Quality: Lessons Learned From the Search for Reliable COVID Tests

Topics We Track

  • Advocacy (2)
  • Committee Reports (1)
  • DOT (5)
  • Drug & Alcohol Testing (17)
  • Drug Legislation (8)
  • Feature (47)
  • FMCSA (3)
  • For Drug Testing Industry Professionals (14)
  • For Employers and Workplace Safety & Wellness Professionals (12)
  • Industry News (8)
  • Marijuana & CBD (13)
  • Member Benefits (1)
  • Membership (2)
  • NDASA Conference (8)
  • NDASA Guidance (4)
  • Opioids (2)
  • Resources (21)
  • Substance Use (1)
  • Substance Use/Addiction (3)
  • Training (1)
  • Uncategorized (7)
  • Workplace Safety (4)

Join NDASA now. Stand for safe and drug-free workplaces and communities.

Click to join

Reach Us



1629 K St. NW, Suite 300
Washington, DC 20006



(888) 31-NDASA



info@NDASA.COM

  • Follow
  • Follow
  • Follow
  • Follow

Leave us a message

Legal Documents

  • Articles of Incorporation
  • Exemption Letter
  • IRS Designation Letter

Careers

Visit our job board

NDASA Bylaws

  • Bylaws

NDASA Policies

  • Privacy Policy
  • Security Policy
  • Refund Policy
  • Shipping Policy

Accreditation

Certification Commission for Drug and Alcohol Program Professionals ( CCDAPP)

Proud Members

U.S. Chamber of Commerce logo

U.S. Chamber of Commerce

 

Smart Approaches to Marijuana

© 2018 National Drug and Alcohol Screening Association • All Rights Reserved • Built by Media Salad